"I am impressed by the independent clinical data showing Brez usage resulted in a significant reduction of more than 50 percent of snoring events. Equally interesting, 88 percent of bed partners reported improved sleep quality when the product was used by the snorer," said George F. Gwinn, MD, clinical investigator, PsyPharma Global, and allergy and pulmonary specialist. "Each day, pharmacists nationwide serve as front-line healthcare providers to help consumers deal with issues such as snoring. Based on these data, it appears that Brez may be an innovative solution that pharmacists can recommend."
In addition to behavioral modifications such as changing sleep positions or weight management to effectively reduce primary snoring, there are a variety of over-the-counter treatments such as throat sprays or outer nasal devices. But, these products have limited efficacy. They are based on a short duration of action or the inherent limitations of external use such as proper placement and comfort issues, internal congestion, or the shape of the user's nose.
"We're pleased to begin our product launch with Rite Aid and independent pharmacies as our partners. Brez is different than anything else on the market today, because it effectively conforms to the user's anatomy to provide a proactive, non-pharmacological solution to snoring," said Mindi S. Osborn, President & CEO, AirWare, Inc. "The inconspicuous, comfortable material enables the user to keep the product in their nose throughout the night, while the convenience of a hygienic, daily disposable breathing aid means people can spend more time sleeping and less time worrying about not sleeping."'/>"/>
|SOURCE AirWare, Inc.|
Copyright©2009 PR Newswire.
All rights reserved